An Open-Label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects With Plaque Psoriasis
Phase of Trial: Phase III
Latest Information Update: 06 Nov 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Registrational
- Sponsors Amgen
- 06 Nov 2017 Results published in the Journal of Clinical Pharmacology.
- 07 Oct 2017 Status changed from active, no longer recruiting to completed.
- 02 Mar 2017 Status changed from completed to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History